Literature DB >> 19255296

Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation.

Steven M Kawut1, Jeffrey Okun2, Daichi Shimbo2, David J Lederer2, Joao De Andrade3, Vibha Lama4, Ashish Shah5, Aaron Milstone6, Lorraine B Ware6, Ann Weinacker7, Ejigayehu Demissie8, Jason D Christie8.   

Abstract

BACKGROUND: Platelet activation with subsequent neutrophilic adherence to the vasculature initiates ischemia-reperfusion injury. We hypothesized that higher plasma P-selectin levels reflecting platelet activation would therefore be associated with primary graft dysfunction (PGD) after lung transplantation.
METHODS: In a prospective, multicenter cohort study of 376 patients who had undergone lung transplantation between 2002 and 2007, we measured soluble P-selectin levels before lung transplantation and at 6 and 24 h after lung reperfusion in 20 patients with grade III PGD (Pao(2)/fraction of inspired oxygen, < 200 mm Hg [with alveolar infiltrates seen on chest radiographs]) at 72 h after transplantation and 61 control subjects without PGD.
RESULTS: Higher postoperative soluble P-selectin levels were associated with an increased risk of PGD at 72 h after transplantation (odds ratio [OR] per 1 natural log increase in soluble P-selectin at 6 h after lung allograft reperfusion, 3.5; 95% confidence interval [CI], 1.01 to 11.8; p = 0.048) and at 24 h after lung allograft reperfusion (OR, 4.8; 95% CI, 1.4 to 16.1; p = 0.01). Higher preoperative mean pulmonary artery pressure and the use of cardiopulmonary bypass were also associated with an increased risk of PGD.
CONCLUSION: Higher postoperative soluble P-selectin levels were associated with an increased risk of PGD at 72 h following lung transplantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19255296      PMCID: PMC2821286          DOI: 10.1378/chest.08-2697

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  29 in total

1.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers.

Authors:  Marc de Perrot; Robert S Bonser; John Dark; Rosemary F Kelly; David McGiffin; Rebecca Menza; Octavio Pajaro; Stephan Schueler; Geert M Verleden
Journal:  J Heart Lung Transplant       Date:  2005-08-08       Impact factor: 10.247

2.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: recipient-related risk factors and markers.

Authors:  Mark L Barr; Steven M Kawut; Timothy P Whelan; Reda Girgis; Heidi Böttcher; Joshua Sonett; Wickii Vigneswaran; David M Follette; Paul A Corris
Journal:  J Heart Lung Transplant       Date:  2005-07-27       Impact factor: 10.247

3.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.

Authors:  Jason D Christie; Martin Carby; Remzi Bag; Paul Corris; Marshall Hertz; David Weill
Journal:  J Heart Lung Transplant       Date:  2005-06-04       Impact factor: 10.247

4.  Soluble form of P-selectin in plasma is elevated in acute lung injury.

Authors:  F Sakamaki; A Ishizaka; M Handa; S Fujishima; T Urano; K Sayama; H Nakamura; M Kanazawa; T Kawashiro; M Katayama
Journal:  Am J Respir Crit Care Med       Date:  1995-06       Impact factor: 21.405

5.  Failure to express the P-selectin gene or P-selectin blockade confers early pulmonary protection after lung ischemia or transplantation.

Authors:  Y Naka; K Toda; K Kayano; M C Oz; D J Pinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

6.  Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease.

Authors:  M I Furman; S E Benoit; M R Barnard; C R Valeri; M L Borbone; R C Becker; H B Hechtman; A D Michelson
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

7.  Impact of primary graft failure on outcomes following lung transplantation.

Authors:  Jason D Christie; Jeffrey S Sager; Stephen E Kimmel; Vivek N Ahya; Christina Gaughan; Nancy P Blumenthal; Robert M Kotloff
Journal:  Chest       Date:  2005-01       Impact factor: 9.410

8.  The effect of primary graft dysfunction on survival after lung transplantation.

Authors:  Jason D Christie; Robert M Kotloff; Vivek N Ahya; Gregory Tino; Alberto Pochettino; Christina Gaughan; Ejigayehu DeMissie; Stephen E Kimmel
Journal:  Am J Respir Crit Care Med       Date:  2005-03-11       Impact factor: 21.405

9.  Primary graft failure following lung transplantation.

Authors:  J D Christie; J E Bavaria; H I Palevsky; L Litzky; N P Blumenthal; L R Kaiser; R M Kotloff
Journal:  Chest       Date:  1998-07       Impact factor: 9.410

10.  Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory responses.

Authors:  D W Hartwell; T N Mayadas; G Berger; P S Frenette; H Rayburn; R O Hynes; D D Wagner
Journal:  J Cell Biol       Date:  1998-11-16       Impact factor: 10.539

View more
  15 in total

1.  Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.

Authors:  J M Diamond; S M Kawut; D J Lederer; V N Ahya; B Kohl; J Sonett; S M Palmer; M Crespo; K Wille; V N Lama; P D Shah; J Orens; S Bhorade; A Weinacker; E Demissie; S Bellamy; J D Christie; L B Ware
Journal:  Am J Transplant       Date:  2011-02-07       Impact factor: 8.086

2.  Postoperative estradiol levels associate with development of primary graft dysfunction in lung transplantation patients.

Authors:  Julie A Bastarache; Joshua M Diamond; Steven M Kawut; David J Lederer; Lorraine B Ware; Jason D Christie
Journal:  Gend Med       Date:  2012-02-22

3.  Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis.

Authors:  Adam Fang; Sean Studer; Steven M Kawut; Vivek N Ahya; James Lee; Keith Wille; Vibha Lama; Lorraine Ware; Jonathan Orens; Ann Weinacker; Scott M Palmer; Maria Crespo; David J Lederer; Clifford S Deutschman; Benjamin A Kohl; Scarlett Bellamy; Ejigayehu Demissie; Jason D Christie
Journal:  Chest       Date:  2010-09-23       Impact factor: 9.410

Review 4.  Primary graft dysfunction.

Authors:  Yoshikazu Suzuki; Edward Cantu; Jason D Christie
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

5.  Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.

Authors:  David J Lederer; Steven M Kawut; Nancy Wickersham; Christopher Winterbottom; Sangeeta Bhorade; Scott M Palmer; James Lee; Joshua M Diamond; Keith M Wille; Ann Weinacker; Vibha N Lama; Maria Crespo; Jonathan B Orens; Joshua R Sonett; Selim M Arcasoy; Lorraine B Ware; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

Review 6.  Platelets: versatile modifiers of innate and adaptive immune responses to transplants.

Authors:  William M Baldwin; Hsiao-Hsuan Kuo; Craig N Morrell
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

7.  Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.

Authors:  David M Sayah; Beñat Mallavia; Fengchun Liu; Guadalupe Ortiz-Muñoz; Axelle Caudrillier; Ariss DerHovanessian; David J Ross; Joseph P Lynch; Rajan Saggar; Abbas Ardehali; Lorraine B Ware; Jason D Christie; John A Belperio; Mark R Looney
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

8.  Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.

Authors:  Joshua M Diamond; Tatiana Akimova; Altaf Kazi; Rupal J Shah; Edward Cantu; Rui Feng; Matthew H Levine; Steven M Kawut; Nuala J Meyer; James C Lee; Wayne W Hancock; Richard Aplenc; Lorraine B Ware; Scott M Palmer; Sangeeta Bhorade; Vibha N Lama; Ann Weinacker; Jonathan Orens; Keith Wille; Maria Crespo; David J Lederer; Selim Arcasoy; Ejigayehu Demissie; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2014-03-01       Impact factor: 21.405

9.  Preoperative echocardiographic-defined moderate-severe pulmonary hypertension predicts prolonged duration of mechanical ventilation following lung transplantation for patients with COPD.

Authors:  Jeremy P Wrobel; Bruce R Thompson; Gregory I Snell; Trevor J Williams
Journal:  Lung       Date:  2012-10-12       Impact factor: 2.584

Review 10.  Genetic polymorphisms associated with acute lung injury.

Authors:  Anita J Reddy; Steven R Kleeberger
Journal:  Pharmacogenomics       Date:  2009-09       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.